ExeVir Bio
PrivateLast Round
Grant
Jun 28, 2023
Total Funding Raised
$108.78M
Company Overview
ExeVir Bio is a biotechnology company that develops single-domain antibody-based therapies for the treatment and prevention of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExeVir Bio Comparables
Compare ExeVir Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiosCURE Therapeutics SE | 89% | |
| Cerberus Therapeutics | 82% | |
| Invivyd | 79% | |
ExeVir Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2023 | ||||
| Debt | Dec 14, 2022 | ||||
| Grant | Jul 13, 2021 | ||||
| Series A | Mar 16, 2021 | ||||
| Series A | Jul 28, 2020 |
Key People
Founding team and executive leadership
ExeVir Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series A |
| Federal Holding and Investment Company | Series A |
| Sopartec | Series A |
| Noshaq | Series A |
| Fund+ | Series A |
| Société Régionale d'Investissement de Wallonie | Series A |
| UCB Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2023
$1.74M grant received from VLAIO.
- Dec 14, 2022
$27M round from European Investment Bank Group.
ExeVir Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ExeVir Bio's valuation, stock price, and market status.